PMID:40131143 Scientific Journal Author Predrag Sikiri, MD, PhD Department of Pharmacology, University of Zagreb School of Medicine Landmark Publications Sikiri P, Petek M, Rucman R, et al
Consequently, potential users should exercise caution and consult healthcare professionals regarding its use, especially because of cancer risks associated with its angiogenic effects 4
The Bridge program currently covers specific GLP-1 medications that hold FDA approval for weight loss
This peptide works by promoting blood flow to damaged tissues, stimulating collagen production, and protecting against further damage
They are commonly recommended as part of Vitamin B12 deficiency treatment, especially for moderate to severe deficiency